Star Combo Pharma

Star Combo Pharma Debt

The Debt of Star Combo Pharma (S66.AX) as of Nov 12, 2026 is 4.19 M AUD. In the previous year, Debt was 3.93 M AUD — a change of 6.57% (higher).

Debt

4.19 MAUD

YoY

6.57%

Last updated:

In 2026, Star Combo Pharma's total debt was 4.19 M AUD, a 6.57% change from the 3.93 M AUD total debt recorded in the previous year.

The Star Combo Pharma Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2019
57,859.00 AUD
Jan 1, 2020
5.61 M AUD
Jan 1, 2021
3.30 M AUD
Jan 1, 2022
4.12 M AUD
Jan 1, 2023
4.19 M AUD
Jan 1, 2024
4.03 M AUD
Jan 1, 2025
3.93 M AUD
Jan 1, 2026
4.19 M AUD
The Star Combo Pharma Debt history
YEARDebtYoY
4.19 MAUD+6.57%
3.93 MAUD-2.40%
4.03 MAUD-3.90%
4.19 MAUD+1.71%
4.12 MAUD+25.06%
3.30 MAUD-41.30%
5.61 MAUD+9,602.83%
57,859.00AUD-57.32%
135,551.00AUD-91.64%
1.62 MAUD+30.10%
1.25 MAUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Star Combo Pharma Stock analysis

What does Star Combo Pharma do? Star Combo Pharma is one of the most popular companies on Eulerpool.

Debt Details

Understanding Star Combo Pharma's Debt Structure

Star Combo Pharma's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Star Combo Pharma's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Star Combo Pharma’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Star Combo Pharma’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Star Combo Pharma stock

Debt of Star Combo Pharma is 4.19 M AUD in 2026.

Debt of Star Combo Pharma changed from 3.93 M AUD to 4.19 M AUD, representing a 6.57% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Debt Star Combo Pharma since 2006 – with annual values, charts, and detailed analysis.

Debt's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's Star Combo Pharma historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Star Combo Pharma

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Star Combo Pharma